Our top pick for
Viemed Healthcare, Inc is a medical devices business based in the US. Viemed Healthcare shares (VMD) are listed on the NASDAQ and all prices are listed in US Dollars. Viemed Healthcare employs 499 staff and has a trailing 12-month revenue of around USD$121.6 million.
|52-week range||USD$2.44 - USD$11.93|
|50-day moving average||USD$9.4743|
|200-day moving average||USD$9.1718|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.25|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Viemed Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Viemed Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Viemed Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Viemed Healthcare shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Viemed Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$26.9 million.
The EBITDA is a measure of a Viemed Healthcare's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$121.6 million|
|Operating margin TTM||14.92%|
|Gross profit TTM||USD$56 million|
|Return on assets TTM||11.69%|
|Return on equity TTM||48.57%|
|Market capitalisation||USD$379 million|
TTM: trailing 12 months
There are currently 1.3 million Viemed Healthcare shares held short by investors – that's known as Viemed Healthcare's "short interest". This figure is 1.2% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting Viemed Healthcare shares can be evaluated.
Viemed Healthcare's "short interest ratio" (SIR) is the quantity of Viemed Healthcare shares currently shorted divided by the average quantity of Viemed Healthcare shares traded daily (recently around 193377.8280543). Viemed Healthcare's SIR currently stands at 6.63. In other words for every 100,000 Viemed Healthcare shares traded daily on the market, roughly 6630 shares are currently held short.
However Viemed Healthcare's short interest can also be evaluated against the total number of Viemed Healthcare shares, or, against the total number of tradable Viemed Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Viemed Healthcare's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Viemed Healthcare shares in existence, roughly 30 shares are currently held short) or 0.0365% of the tradable shares (for every 100,000 tradable Viemed Healthcare shares, roughly 37 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Viemed Healthcare.
Find out more about how you can short Viemed Healthcare stock.
We're not expecting Viemed Healthcare to pay a dividend over the next 12 months.
Over the last 12 months, Viemed Healthcare's shares have ranged in value from as little as $2.44 up to $11.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viemed Healthcare's is 0.7622. This would suggest that Viemed Healthcare's shares are less volatile than average (for this exchange).
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.